Global Tumor Ablation Market Analysis and Forecast 2024-2030

Global Tumor Ablation Market Analysis and Forecast 2024-2030


Summary

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

According to APO Research, The global Tumor Ablation market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Tumor Ablation is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Tumor Ablation include Angiodynamics, Medtronic, Boston Scientific, Misonix, Sonacare Medical, EDAP TMS, Chongqing Haifu Medical, HealthTronics and J &J, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tumor Ablation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tumor Ablation, also provides the sales of main regions and countries. Of the upcoming market potential for Tumor Ablation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tumor Ablation sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tumor Ablation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tumor Ablation sales, projected growth trends, production technology, application and end-user industry.

Tumor Ablation segment by Company

Angiodynamics
Medtronic
Boston Scientific
Misonix
Sonacare Medical
EDAP TMS
Chongqing Haifu Medical
HealthTronics
J &J
Tumor Ablation segment by Type

Radiofrequency (RF) Ablation
Microwave Ablation
Cryoablation
Other Technologies
Tumor Ablation segment by Application

Liver Cancer
Lung Cancer
Kidney Cancer
Others
Tumor Ablation segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Ablation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tumor Ablation in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Ablation sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Tumor Ablation Market by Type
1.2.1 Global Tumor Ablation Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Radiofrequency (RF) Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other Technologies
1.3 Tumor Ablation Market by Application
1.3.1 Global Tumor Ablation Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Tumor Ablation Market Dynamics
2.1 Tumor Ablation Industry Trends
2.2 Tumor Ablation Industry Drivers
2.3 Tumor Ablation Industry Opportunities and Challenges
2.4 Tumor Ablation Industry Restraints
3 Global Market Growth Prospects
3.1 Global Tumor Ablation Revenue Estimates and Forecasts (2019-2030)
3.2 Global Tumor Ablation Revenue by Region
3.2.1 Global Tumor Ablation Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Tumor Ablation Revenue by Region (2019-2024)
3.2.3 Global Tumor Ablation Revenue by Region (2025-2030)
3.2.4 Global Tumor Ablation Revenue Market Share by Region (2019-2030)
3.3 Global Tumor Ablation Sales Estimates and Forecasts 2019-2030
3.4 Global Tumor Ablation Sales by Region
3.4.1 Global Tumor Ablation Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Tumor Ablation Sales by Region (2019-2024)
3.4.3 Global Tumor Ablation Sales by Region (2025-2030)
3.4.4 Global Tumor Ablation Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Tumor Ablation Revenue by Manufacturers
4.1.1 Global Tumor Ablation Revenue by Manufacturers (2019-2024)
4.1.2 Global Tumor Ablation Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Tumor Ablation Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Tumor Ablation Sales by Manufacturers
4.2.1 Global Tumor Ablation Sales by Manufacturers (2019-2024)
4.2.2 Global Tumor Ablation Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Tumor Ablation Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Tumor Ablation Sales Price by Manufacturers (2019-2024)
4.4 Global Tumor Ablation Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Tumor Ablation Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Tumor Ablation Manufacturers, Product Type & Application
4.7 Global Tumor Ablation Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Tumor Ablation Market CR5 and HHI
4.8.2 2023 Tumor Ablation Tier 1, Tier 2, and Tier 3
5 Tumor Ablation Market by Type
5.1 Global Tumor Ablation Revenue by Type
5.1.1 Global Tumor Ablation Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Tumor Ablation Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Tumor Ablation Revenue Market Share by Type (2019-2030)
5.2 Global Tumor Ablation Sales by Type
5.2.1 Global Tumor Ablation Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Tumor Ablation Sales by Type (2019-2030) & (Units)
5.2.3 Global Tumor Ablation Sales Market Share by Type (2019-2030)
5.3 Global Tumor Ablation Price by Type
6 Tumor Ablation Market by Application
6.1 Global Tumor Ablation Revenue by Application
6.1.1 Global Tumor Ablation Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Tumor Ablation Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Tumor Ablation Revenue Market Share by Application (2019-2030)
6.2 Global Tumor Ablation Sales by Application
6.2.1 Global Tumor Ablation Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Tumor Ablation Sales by Application (2019-2030) & (Units)
6.2.3 Global Tumor Ablation Sales Market Share by Application (2019-2030)
6.3 Global Tumor Ablation Price by Application
7 Company Profiles
7.1 Angiodynamics
7.1.1 Angiodynamics Comapny Information
7.1.2 Angiodynamics Business Overview
7.1.3 Angiodynamics Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Angiodynamics Tumor Ablation Product Portfolio
7.1.5 Angiodynamics Recent Developments
7.2 Medtronic
7.2.1 Medtronic Comapny Information
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Medtronic Tumor Ablation Product Portfolio
7.2.5 Medtronic Recent Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Comapny Information
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Boston Scientific Tumor Ablation Product Portfolio
7.3.5 Boston Scientific Recent Developments
7.4 Misonix
7.4.1 Misonix Comapny Information
7.4.2 Misonix Business Overview
7.4.3 Misonix Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Misonix Tumor Ablation Product Portfolio
7.4.5 Misonix Recent Developments
7.5 Sonacare Medical
7.5.1 Sonacare Medical Comapny Information
7.5.2 Sonacare Medical Business Overview
7.5.3 Sonacare Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Sonacare Medical Tumor Ablation Product Portfolio
7.5.5 Sonacare Medical Recent Developments
7.6 EDAP TMS
7.6.1 EDAP TMS Comapny Information
7.6.2 EDAP TMS Business Overview
7.6.3 EDAP TMS Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 EDAP TMS Tumor Ablation Product Portfolio
7.6.5 EDAP TMS Recent Developments
7.7 Chongqing Haifu Medical
7.7.1 Chongqing Haifu Medical Comapny Information
7.7.2 Chongqing Haifu Medical Business Overview
7.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
7.7.5 Chongqing Haifu Medical Recent Developments
7.8 HealthTronics
7.8.1 HealthTronics Comapny Information
7.8.2 HealthTronics Business Overview
7.8.3 HealthTronics Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 HealthTronics Tumor Ablation Product Portfolio
7.8.5 HealthTronics Recent Developments
7.9 J &J
7.9.1 J &J Comapny Information
7.9.2 J &J Business Overview
7.9.3 J &J Tumor Ablation Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 J &J Tumor Ablation Product Portfolio
7.9.5 J &J Recent Developments
8 North America
8.1 North America Tumor Ablation Market Size by Type
8.1.1 North America Tumor Ablation Revenue by Type (2019-2030)
8.1.2 North America Tumor Ablation Sales by Type (2019-2030)
8.1.3 North America Tumor Ablation Price by Type (2019-2030)
8.2 North America Tumor Ablation Market Size by Application
8.2.1 North America Tumor Ablation Revenue by Application (2019-2030)
8.2.2 North America Tumor Ablation Sales by Application (2019-2030)
8.2.3 North America Tumor Ablation Price by Application (2019-2030)
8.3 North America Tumor Ablation Market Size by Country
8.3.1 North America Tumor Ablation Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Tumor Ablation Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Tumor Ablation Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Tumor Ablation Market Size by Type
9.1.1 Europe Tumor Ablation Revenue by Type (2019-2030)
9.1.2 Europe Tumor Ablation Sales by Type (2019-2030)
9.1.3 Europe Tumor Ablation Price by Type (2019-2030)
9.2 Europe Tumor Ablation Market Size by Application
9.2.1 Europe Tumor Ablation Revenue by Application (2019-2030)
9.2.2 Europe Tumor Ablation Sales by Application (2019-2030)
9.2.3 Europe Tumor Ablation Price by Application (2019-2030)
9.3 Europe Tumor Ablation Market Size by Country
9.3.1 Europe Tumor Ablation Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Tumor Ablation Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Tumor Ablation Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Tumor Ablation Market Size by Type
10.1.1 China Tumor Ablation Revenue by Type (2019-2030)
10.1.2 China Tumor Ablation Sales by Type (2019-2030)
10.1.3 China Tumor Ablation Price by Type (2019-2030)
10.2 China Tumor Ablation Market Size by Application
10.2.1 China Tumor Ablation Revenue by Application (2019-2030)
10.2.2 China Tumor Ablation Sales by Application (2019-2030)
10.2.3 China Tumor Ablation Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Tumor Ablation Market Size by Type
11.1.1 Asia Tumor Ablation Revenue by Type (2019-2030)
11.1.2 Asia Tumor Ablation Sales by Type (2019-2030)
11.1.3 Asia Tumor Ablation Price by Type (2019-2030)
11.2 Asia Tumor Ablation Market Size by Application
11.2.1 Asia Tumor Ablation Revenue by Application (2019-2030)
11.2.2 Asia Tumor Ablation Sales by Application (2019-2030)
11.2.3 Asia Tumor Ablation Price by Application (2019-2030)
11.3 Asia Tumor Ablation Market Size by Country
11.3.1 Asia Tumor Ablation Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Tumor Ablation Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Tumor Ablation Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Tumor Ablation Market Size by Type
12.1.1 MEALA Tumor Ablation Revenue by Type (2019-2030)
12.1.2 MEALA Tumor Ablation Sales by Type (2019-2030)
12.1.3 MEALA Tumor Ablation Price by Type (2019-2030)
12.2 MEALA Tumor Ablation Market Size by Application
12.2.1 MEALA Tumor Ablation Revenue by Application (2019-2030)
12.2.2 MEALA Tumor Ablation Sales by Application (2019-2030)
12.2.3 MEALA Tumor Ablation Price by Application (2019-2030)
12.3 MEALA Tumor Ablation Market Size by Country
12.3.1 MEALA Tumor Ablation Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Tumor Ablation Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Tumor Ablation Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Tumor Ablation Value Chain Analysis
13.1.1 Tumor Ablation Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Tumor Ablation Production Mode & Process
13.2 Tumor Ablation Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Tumor Ablation Distributors
13.2.3 Tumor Ablation Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings